The economic impact of morbid obesity

Frezza, Eldo E.; Wachtel, Mitchell S.

doi:10.1007/s00464-008-0325-y

Cited by 15 publications

(28 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The improvement or resolution of comorbidities is directly related to this. It is known that comorbidities such as DM2, SAH, and dyslipidemias improve, with some being completely resolved, after bariatric surgery [2][3][4][5]11] According to cardiology directives, the prevalence of SAH is over 30%, in accordance with population surveys conducted in Brazilian cities in the last 20 years. SAH has a high prevalence and low rates of control, where it is considered one of the most important public health problems.…”

Section: Discussionmentioning

confidence: 87%

“…According to Christou [14], obese patients without surgery require more health care services, which make them more burdensome, because obesity can lead to various associated diseases, and these complications result in high costs [10,11]. However, operated individuals show a high need for health care services up to the end of the first year after bariatric surgery [2].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Economic Benefits of Bariatric Surgery

Sussenbach¹,

Padoin²,

Silva³

et al. 2011

OBES SURG

View full text Add to dashboard Cite

With the high prevalence of obesity and associated comorbidities, the costs of health services produce a great economic impact. The objective of this work was to evaluate the economic benefits of bariatric surgery and to relate the costs to the impact on the health of the individual. A historic cohort study was conducted, with review of medical charts of 194 patients who fulfilled the inclusion criteria for the study. The costs for medications, professional care, and examinations in the pre- and postoperative periods were analyzed, taking into consideration the comorbidities DM2, SAH, and dyslipidemia. The study demonstrated a reduction in the medical costs in the course of the postoperative period, in relation to expenses for medications, professional care, and examinations in the preoperative period. Comparing the preoperative expenses with different times in the postoperative period, a statistically significant difference was seen at all time evaluated (p < 0.001). The resolution of comorbidities was higher than 95% at 36 months after surgery. No statistically significant difference was seen with respect to the prevalence of comorbidities between the sexes in the pre- and postoperative periods (p > 0.05). With regard to age, younger patients showed lower rates of comorbidities in the pre- and postoperative periods (p < 0.001). The costs of the surgery are high, but the expenditures for medications, professional care, and examinations decrease progressively after the operation, where this is more evident in patients with more associated comorbidities.

show abstract

Section: Discussionmentioning

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Economic Benefits of Bariatric Surgery

Sussenbach¹,

Padoin²,

Silva³

et al. 2011

OBES SURG

View full text Add to dashboard Cite

show abstract

“…32 Obesity is also associated with significant financial implications for the world economy. 33 Obesity appears to be an important issue among children and adolescents.…”

Section: Introductionmentioning

confidence: 99%

Organic consequences of ileal transposition in rats with diet-induced obesity

et al. 2011

View full text Add to dashboard Cite

INTRODUCTION:The clinical management of metabolic syndrome -especially diabetes mellitus type 2 -is notoriously complex due to the progressive nature of this disease. At present, there is a need for a surgical procedure that is effective for the treatment of diabetes mellitus type 2, even in non-obese individuals. The isolated ileal transposition theory could lead to an effective alternative therapy. This intervention has not yet been performed in humans, and there are no reports of its use in an experimental model of diet-induced metabolic syndrome. OBJECTIVES:The objective of this study is to evaluate the physiological effects of ileal transposition in rats with diet-induced metabolic syndrome. The effects of this procedure on glucose and lipid metabolism will be assessed. METHODS:Forty 12-week-old male rats (albino Rattus norvegicus, Wistar, 2BAW, heterogeneous) will be divided into four groups of 10 animals each: the ileal transposition group (TG) comprising animals on a hypercaloric-hyperlipidic diet; the sham group (SG) containing animals that receive the same diet and undergo the sham surgery; control group 1 (CG1), which will receive a hypercaloric-hyperlipidic diet and will not undergo surgery; and control group 2 (CG2), which will consume standard feed and will not undergo surgery. The surgeries will be performed in 20-week-old animals.Blood samples for laboratory testing will be collected from 12-week-old animals on the day of surgery and after eight postoperative weeks, following determination of the weights of the animals and the administration of anesthesia. The levels of serum glucose, insulin, triglycerides, total cholesterol and fractions, glucagon-like peptide-1, C-peptide and glycated hemoglobin will be assessed in all of the animals. The insulin tolerance test will be performed using PRISMA software, and insulin resistance will be calculated by the HOMA-IR indirect test. On specific days, two 20-week-old rats will be separated and randomly distributed in TG and SG. These animals will be followed until the eighth postoperative week. Subsequently, they will be euthanized, and the retroperitoneal and periepididymal fat deposits will be collected and weighed using a precision scale. In addition, the pancreas, liver and intestinal segments will be sent for pathological and immunohistochemical studies.

show abstract

“…Obesity may cost New Mexico more than 7,300 jobs and cuts state and local tax revenues by more than US$48 million. (Frezza and Wachtel 2009) Few studies have examined the impact of bariatric surgery on productivity. According to a US analysis, obese workers eligible for bariatric surgery have 5.1 (P <0.01) additional days of absenteeism and US$2,230 (in 2004 dollars) (P<0.01) higher annual medical costs than persons of a BMI of less than 25.…”

Section: Effect On Productivity (Paid Work)mentioning

confidence: 99%

“…(Finkelstein and Brown 2005) Given that bariatric surgery has been shown to increase life expectancy and to reduce the impact of overweight and comorbidities an increase in productivity would be expected. (Frezza and Wachtel 2009) A retrospective analysis in the Duke Health and Safety Surveillance System compared data of morbidly obese workers (BMI ≥ 40) with workers with a BMI 18.5 to 24.9 and revealed that the obese workers generated twice the amount of claims with 6.8 times higher medical claims cost and 11 times higher indemnity claims cost. In addition they lost 12.9 times more workdays than the non-obese workers.…”

Section: Effect On Productivity (Paid Work)mentioning

confidence: 99%